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This overview highlights the importance of characterization of biogenic nanoparticles of 
silver and silver chloride in order to understand the action on ticks or pathogens transmitted 
by them. These nanoparticles appear as important active principles in this area. They can act 
against ticks or against major pathogens transmitted by the bite of ticks such as bacteria, viruses 
or protozoa with equal or better efficacy of antibiotics, antiviral or antiparasitic agents. Anti-tick 
activities on Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum, Hyalomma isaaci and 
Haemaphysalis bispinosa are discussed. Perspectives of these nanoparticles acting on bacteria, 
viruses and protozoa infections are also discussed.
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1. Introduction
Ticks are vectors of many infections as they are able to 
carry bacteria, virus and also protozoan agents.1 Related to 
the bacterial diseases transmitted by ticks are Lyme disease, 
rickettsioses, and tularemia.2-7
Tiboviruses (tick-borne viruses) cause many symptoms 
with severe effects that affect the central nervous system, 
such as meningitis, meningoencephalitis with high 
sequelae, and hemorrhagic diseases.8-10
Protozoan infections, for example, the babesiosis 
(Babesia bigemina), may also be transmitted by 
ticks.11-13 Toxin production can cause paralysis, from 
Dermacentor andersoni (Rocky Mountain wood tick), 
Dermacentor variabilis (dog ticks), and Ixodes holocyclus 
(marsupial ticks).14-16 In this last and rare case, the mainstay 
of treatment for tick’s paralysis, tick removal, and the time 
to full neurological recovery after tick removal are generally 
estimated to be around 1.5 days with initial improvement 
within hours.17,18
In Brazil, the main disease transmitted by ticks to 
humans is spotted fever (BSF) whose etiologic agent is 
Rickettsia rickettsii, which is an intracellular gram-negative 
bacterium. The main vector is Amblyomma sculptum 
and the disease is considered a major public health 
problem.19,20
The rise in the number of notified cases and the 
expansion of transmission area and elevated lethality rate 
have been observed in the country since 80’s. Lethality rate 
in the southeast region of Brazil ranges between 30 to 50%, 
and in São Paulo and Minas Gerais states one can found 
the most notifications of this disease.19,21
An excellent alternative for treatment of these diseases 
is the use of nanobiotechnology as a novel strategy in this 
area. One important nanostructure is the silver nanoparticles 
(Ag0) or also nanoparticles of the silver cloride (AgCl).
The silver nanoparticles biogenically synthesized are 
widely studied by many research groups in the world22-39 
and Ag0 nanoparticles were quite efficient against 
Aedes aegypti.40
The biogenic silver nanoparticles effects on ticks were 
studied against ticks’ larvae and adult ticks.41,42
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It is important to be aware that the characterizations of 
these silver nanostructures are of paramount importance, 
since there are many reports in the literature in which 
erroneous characterization of silver structures were 
published. The X-ray diffraction (XRD) pattern for Ag0 as 
well as for AgCl nanoparticles, which are the most common 
silver nanostructures that are biogenically synthesized, 
were discussed recently by Seabra et al.43 Based on 
aforementioned discussion on XRD characterization of 
biogenic silver nanostructures, herein the anti-tick activities 
are to be discussed.
The XRD patterns for Ag0 nanoparticles (JCPDS 
file No. 04-0783 or ICSD Code 64994) and for AgCl 
nanoparticles (JCPDS file No. 85-1355 or ICSD Code 
64734) were used to construct Table 1.
2. Anti-Tick Activity
Marimuthu et al.42 biosynthesized silver nanoparticles 
from leaf extract of Mimosa pudica Gaertn. (Mimosaceae) 
and tested those nanoparticles against the larvae of 
Rhipicephalus (Boophilus) microplus Canestrini, 1887 
(Acari: Ixodidae) (R. (B.) microplus). In this case the 
silver nanostructure was classified as Ag0 nanoparticles. 
Analyzing the XRD pattern data the nanostructure 
studied also exhibited values that correspond to AgCl 
nanoparticles (low presence) Ag0 and/or silver oxides as 
spherical morphology. Reported nanoparticles exhibited 
an efficacy of LC50 of 8.98 μg mL-1 against the larvae of 
R. (B.) microplus. At the concentration of 15 and 20 μg mL-1, 
a 51 and 89% of mortality was found, respectively. The size 
of the nanoparticles by transmission electron microscopy 
(TEM) was around 25-60 nm and by scanning electron 
microscopy (SEM) were 25-50 nm.
The synthesis of mainly AgCl nanoparticles and with 
presence of low Ag0 nanoparticles silver nanoparticles 
from leaf extract of Ocimum canum Sims (Labiatae) 
against the larvae of Hyalomma anatolicum (a.) anatolicum 
Koch,  1844 (actual  name H. anatolicum)  and 
Hyalomma marginatum (m.) isaaci Sharif, 1928 (Acari: 
Ixodidae) (actual name H. isaaci) was achieved.41 
SEM analyses were crucial to determine the size of the 
synthesized AgCl nanoparticles that was estimated to 
be 25-110 nm. The particles exhibited spherical and 
after drying formed rod and cubic morphology. These 
nanoparticles exhibited effect against H. anatolicum and 
H. isaaci with the LC50 values of 0.78 and 1.00 μg mL-1, 
respectively, and caused 100% mortality at 2.5 μg mL-1. 
Probably, in this case the cubic form of AgCl exerted a 
better activity than AgCl in its spherical morphology.47 It 
is known that spherical and cubes as in the case of AgCl in 
this case, exhibits similar biological activities.
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against the larvae of R. (B.) microplus were studied.48 The 
size of the nanoparticles as determined by FESEM was 
43 nm. The activity against the larvae of R. (B.) microplus 
exhibited LC50 values of 7.61 and at 25 μg mL-1 and 100% 
of mortality for adult R. (B.) microplus was also observed. 
This nanostructure exhibited lower activity than any Ag0, 
since this nanoparticle is spherical as in Marimuthu et al.42
Aqueous leaf extract from Musa paradisiaca (L.) 
(Musaceae) led to the synthesis of silver nanoparticles 
(mainly) and some AgCl nanoparticles were also 
present and their application against the larvae of 
Haemaphysalis bispinosa Neumann (Acarina: Ixodidae) 
(H. bispinosa) was reported.44 By SEM the size was 
20-30 nm and exhibiting the LC50 of 1.87 μg mL-1 and at 
concentration of 5 μg mL-1, those nanoparticles provoked 
100% of mortality. The spherical morphology in Ag0 
exerted an important biological activity.
Aqueous leaf extract from Euphorbia prostrata Ait. 
was used for the synthesis Ag0 nanoparticles (mainly with 
traces of AgCl nanoparticles) and studied against the adult 
cattle tick H. bispinosa.45 SEM analysis showed a size of 
25-80 nm. The LC50 value observed was 2.3 μg mL-1 and 
100% of mortality at 10 μg mL-1 nanoparticles. In this 
preparation the Ag0 presented a spherical morphology and 
similar activities than in the work of Marimuthu et al.42
Rajakumar and Rahuman46 synthesized from aqueous 
extract of Manilkara zapota (L.) mainly Ag0 nanoparticles 
(spherical morphology) and traces of AgCl nanoparticles 
as seen by XRD pattern. A size of 70-140 nm by SEM 
was determined. LC50 values against R. (B.) microplus was 
3.44 μg mL-1 and at a concentration of 10 μg mL-1 exhibited 
a 100% mortality.
The synthesis of AgCl nanoparticles from Streptomyces sp. 
LK3 showed acaricidal activity against R. (B.) microplus and 
H. bispinosa with LC50 values of 16.10 and 16.45 μg mL-1, 
respectively.47 In this case, the exhibited plasmon absorption 
can be associated to a very low Ag0 nanoparticles 
concentration present. The presence of AgCl in its spherical 
form exerts a low activity as compared with Ag0.
Evaluat ion  of  acar ic idal  e fficacy (agains t 
R. (B.) microplus) of plant mediated synthesis of silver 
nanoparticles using Carissa carandas leaf extract 
(40-50 nm by TEM) was reported. Adult immersion test 
was used to evaluate the efficacy of silver nanoparticles 
against cattle ticks. Results showed 40% mortality with 
silver nanoparticles (non characterized by XRD diffractions 
pattern and probably AgCl) using a high concentration 
(5 mg mL-1, 72 h). The effect was further observed on the 
reproductive indices of ticks which exhibited significant 
decrease in this index with increasing concentrations of 
silver nanoparticles.49
Larvae and adult H. bispinosa were affected in the 
same extension (LD50 ca. 2 μg mL-1) and similar mortality 
percentage from Ag0 nanoparticles from different sources 
(Musa paeadisiaca)44 and Euphorbia prostate.45 However, 
AgCl nanoparticles from Streptomyces47 showed to be 
8-fold less effective than ones obtained from the plant 
sources.
Larvae R. (B.) microplus was affected by Ag0 nanoparticles 
differently  when different sources of the Ag0 nanoparticles 
were used. The LD50 from Manilkara zapota (3.44 μg mL-1)46 
and from Mimosa pudica (8.98 μg mL-1)42 were found. At 
the same extension mortality were 3-fold more efficient 
in Manilkara than in Mimosa. In the presence of AgCl 
nanoparticles, the same value of LD50 (7.61 μg mL-1) was 
obtained by the source of Cissus quadrangularis with a 
similar mortality48 against the ticks. AgCl nanoparticles 
produced by Streptomyces exhibited a lower effect against 
the tested ticks (LD50 ca.16 μg mL-1) (Table 1).
Larvae of H. anatolicum and H. marginatum were 
affected significantly by AgCl nanoparticles synthesized by 
Ocimum canum Sims with LD50 of 0.78 and 1.0 μg mL-1, 
respectively.41 Probably, in this case the spherical form that 
after drying formed rod and cubic structures exerted a high 
biological activity in a similar or better profile than Ag0.
It is known that silver triangular nanoplates have basic 
{111} surface, nanospheres and nanocubes mainly have 
{100} planes, and nanorods have {100} side surfaces and 
{111} end facets. Then, the data said that {111} crystal 
plane of silver nanoparticles may play a prime role in 
antibacterial progress. Recently was reported that silver 
triangle nanoplates had the best antibacterial activity, 
while nanospheres, nanocubes and short nanorods showed 
similar efficacy.50
This was reinforced with MIC values of Ag0 nanoparticles 
(60 nm) in which the cubic form and spherical one were 
37.5 and 75 μg mL-1, respectively.51 The fact is, the particles 
covered by {100} facets (cubic form) showed stronger 
antibacterial activity than those covered by {111} facets 
(spherical). This was demonstrated on Table 1.
The Table 1 shows a summary of all the anti-tick 
activities of biogenic silver nanoparticles. Fortunately, with 
the discrimination of the XRD pattern, it was possible to 
get some conclusions.
In conclusion, Ag0 and AgCl nanoparticles are efficient 
anti-tick agents, however, their activities depend on the 
source of production of nanoparticles and from their 
morphologies. Due to this factor, AgCl in its spherical 
morphology exhibited less activity than spherical Ag0.
Another factor that has to be considered when 
evaluating effects of the cited nanoparticles are the effects 
of the capped proteins from the biogenic nanoparticles, 
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which probably due to the specificity of the protein corona 
interaction may strongly affect nanoparticles’ activities.26
3. Tick-Borne Diseases
3.1. Bacteria
Bacteria genera most common in the ticks’ infection 
are Borrelia (a genus of Gram-negative, aerobic, spirochete 
bacteria), Francisella (a genus Gram-negative, aerobic, 
coccobacillary or rod shaped, nonmotile bacteria), 
Coxiella (a genus of Gram-negative, aerobic, rod-shaped 
or spore-like particles, acidophilic bacteria), Rickettsia 
(a genus of non motile, Gram-negative, aerobic, obligate 
intracellular parasites, non spore-forming, highly 
pleomorphic bacteria that can present as cocci) and 
Ehrlichia (a genus of Gram-negative, aerobic, obligate 
intracellular parasites, rickettsia-shaped bacteria).
Burgdorfer,52 who is well known researcher in Lyme 
diseases, tested in vitro proteinate silver (colloidal silver 
or Argyrol) up to 1500 ppm (1.5 mg mL-1) on bacteria that 
cause Lyme disease (Borrelia burgdorferi spirochetes).53,54 
These bacteria disappeared in less than five minutes and 
twenty-four hours later, none of the crops treated contained 
any living spirochetes. Similar results were observed with 
another bacterium, such as Borrelia hermsii (HS-1), the 
agent of relapsing fever.
As far as we know, no other bacteria in this area were 
studied under influence of silver nanoparticles. However, 
it is known from the literature,23,35-38,55 that Gram-negative 
bacteria are effectively eliminated by Ag0 nanoparticles. 
Then, the antibacterial studies regarding tick-borne 
infections are an open area for research.
3.2. Virus
The most known viruses from tick infections are the tick-
borne viruses of the families Asfarviridae, Rhabdoviridae 
and Orthomyxoviridae, Reoviridae, Bunyaviridae and 
Flaviviridae, genus Flavivirus (around 200 viruses).8
Argovit (12 mg mL-1) that is spherical silver nanoparticles 
of 35 ± 15 nm functionalized with poly(vinylpyrrolidone) 
(PVP, 10-30 kD) were tested on Rift Valley fever virus 
(RVFV) in a Vero cell cultures and on mice lacking the 
type I interferon receptor (IFNAR [−/−] mouse infection 
model). In cells infected with RVFV a viral reduction of 
50% of the total virus was found. But, pre-incubation 
of RVFV with silver nanoparticles at concentrations 
of 0.2 mg mL-1, abolished almost completely viral 
propagation, leading to 98% reduction of infectivity. Daily 
administration of silver nanoparticles by oral gavages 
to lethally infected mice, previously incubated with 
20 mg mL-1 of silver nanoparticles showed a delayed-
onset clinical disease and mortality, with a survival rate 
of 60%. The authors suggested that these results revealed 
the potential application of the microbiocide properties 
of silver nanoparticles to control the infectivity of this 
important zoonotic pathogen.56
In addition to the antimicrobial activity against 
bacteria of silver nanoparticles, there is strong evidence 
that they are also active against several viruses, including 
human immunodeficiency virus, hepatitis B virus, herpes 
simplex virus, respiratory syncytial virus and monkey pox 
virus. These metal nanostructures generate an important 
opportunity for the development of new antiviral therapies 
with a large number of targets, reducing viral resistance 
that can commonly happen with conventional antivirals.57
3.3. Protozoan
Protozoan infection babesiosis (Babesia bigemina) 
is transmitted by ticks13 and, in a similar way, 
leptospirosis by Ixodes ricinus58 and leishmaniasis by 
Rhipicephalus sanguineus.59
The effectiveness of silver nanoparticles as an alternative 
therapy for leishmaniasis, specifically by subcutaneous 
intralesional administration for cutaneous leishmaniasis 
was demonstrated.60 Biogenic silver nanoparticles (mainly 
Ag0 nanoparticles) against Leishmania amazonensis 
promastigotes showed to be 4-fold more effective than 
silver nanoparticles chemically synthesized. In vivo studies 
in infected mice demonstrated that the biogenic silver 
nanoparticles were equally effective as 300-fold higher 
doses of amphotericin B, and more effective than 4-fold 
higher doses of chemically synthesized one.61
The possibility of using silver nanoparticles on 
protozoan infections was summarized by Rai et al.62 These 
facts demonstrated that we need more research in order 
to eliminate these types of contamination provoked by 
ticks.
4. Perspectives and Final Remarks
It is important to mention that it was clear from these 
analyzed data that reliable nanoparticles characterization 
and morphology are important in the biological activities. 
Then, the data said that {111} crystal plane of silver 
nanoparticles may play a prime role in antibacterial 
progress.
Another important conclusion is also that either Ag0 or 
AgCl nanoparticles or both together were effective against 
ticks or the propagation of the tick-borne infections. All 
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data indicated that the antibacterial and antiviral studies 
regarding tick-borne infections are an open area for 
research.
Then, we hope that this overview might incentive 
the researchers to study ticks-producer diseases more 
thoroughly in order to eradicate this problem globally.
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